Biotechnology - Neurological, Research

Filter

Current filters:

NeurologicalResearch

Popular Filters

1 to 25 of 81 results

Novogen identifies family of compounds to promote brain stem cell growth

Novogen identifies family of compounds to promote brain stem cell growth

16-01-2015

Australian biotech firm Novogen has announced an important discovery in its regenerative medicine program…

BiotechnologyNeurologicalNovogenResearch

Treeway collaborates with uniQure on gene therapy for ALS

15-01-2015

Netherlands-based biotech firm Treeway has entered into a collaboration with Dutch gene therapy company…

BiotechnologyLicensingNeurologicalResearchTreewayuniQure

Alkermes rises on positive ALKS 5461 results

07-01-2015

Shares of Ireland-headquartered biotech firm Alkermes closed up 2.6% to $60.93, having risen as much…

AlkermesALKS 5461BiotechnologyNeurologicalResearch

23andMe and Genentech in deal to analyze genomic data for Parkinson's disease

06-01-2015

23andMe, the leading personal genetics company, and Genentech, a subsidiary of Swiss pharma giant Roche,…

23andMeBiotechnologyGenentechNeurologicalResearchRoche

Astellas and CoMentis to end Alzheimer’s collaboration

20-10-2014

Japanese drug major Astellas Pharma and US biotech firm CoMentis have said they will end their worldwide…

Astellas PharmaBiotechnologyCoMentisLicensingNeurologicalResearch

Biogen Idec's Plegridy achieves positive results over two years in multiple sclerosis

Biogen Idec's Plegridy achieves positive results over two years in multiple sclerosis

12-09-2014

US biotech firm Biogen Idec has reported data confirming its Plegridy gives provides treatment effects…

Biogen IdecBiotechnologyNeurologicalPlegridyResearchUSA

Strong and sustained efficacy reported for Tecfidera over five years

Strong and sustained efficacy reported for Tecfidera over five years

12-09-2014

Results from a five-year study with US biotech firm Biogen Idec’s Tecfidera show strong and sustained…

Biogen IdecBiotechnologyNeurologicalResearchTecfideraUSA

XenoPort to collaborate with the NIAAA for Horizant trial

XenoPort to collaborate with the NIAAA for Horizant trial

10-09-2014

Neurological biopharma specialist XenoPort is to enter into an agreement with the National Institute…

Alcohol abuseBiotechnologyHorizantNational Institute on Alcohol Abuse and AlcoholismNeurologicalResearchUKXenoPort

AbbVie links with Calico in up to $1.5 billion effort on drug discovery

AbbVie links with Calico in up to $1.5 billion effort on drug discovery

04-09-2014

US pharma company AbbVie has entered a novel R&D collaboration with recently-formed Calico, intended…

AbbVieBiotechnologycalicoNeurologicalOncologyResearch

Regulus shares up on deal with Biogen for microRNA biomarkers in MS

Regulus shares up on deal with Biogen for microRNA biomarkers in MS

05-08-2014

Regulus Therapeutics has entered into a new collaboration agreement with fellow US biotech firm Biogen…

Biogen IdecBiotechnologyMultiple sclerosisNeurologicalRegulus TherapeuticsResearchUSA

Merck & Co in new accord with Bionomics for CNS research

Merck & Co in new accord with Bionomics for CNS research

24-06-2014

Australian biotech firm Bionomics has entered into a second exclusive research collaboration and license…

BionomicsBiotechnologyBNC375LicensingMerck & CoNeurologicalResearch

Isis Pharma earns $10 million milestone from Biogen

Isis Pharma earns $10 million milestone from Biogen

17-06-2014

Isis Pharmaceuticals revealed today it has earned a $10 million milestone payment from fellow US biotech…

Biogen IdecBiotechnologyFinancialIsis PharmaceuticalsNeurologicalResearch

KemPharm gets $60 million funding commitment from Deerfield

KemPharm gets $60 million funding commitment from Deerfield

06-06-2014

KemPharm, a clinical-stage US biopharmaceutical company, has entered into a $60 million financing agreement…

BiotechnologyFinancialKemPharmKP201NeurologicalResearch

AFFiRiS reports breakthrough in Alzheimer's disease with AD04

AFFiRiS reports breakthrough in Alzheimer's disease with AD04

05-06-2014

Austrian biotech firm AFFiRiS has released Phase II results with its proprietary AD04 vaccine, saying…

AD04AFFiRiSBiotechnologyGlaxoSmithKlineNeurologicalResearch

Eisai's R&D unit Kan Research Institute starts full-scale operation at new facility

27-05-2014

Japanese drug major Eisai Co says that its R&D subsidiary KAN Research Institute held a dedication ceremony…

BiotechnologyEisaiImmunologicalsJapanKan Research InstituteNeurologicalOncologyResearch

AAN 2014: Biogen Idec releases new trial data for peginterferon in MS

AAN 2014: Biogen Idec releases new trial data for peginterferon in MS

02-05-2014

US biotech firm Biogen Idec has released new two-year data from the Phase III ADVANCE clinical trial…

Biogen IdecBiotechnologyCytokinesHealth Medical PharmaHealth Medical PharmaImmune systemImmunologyNeurologicalpeginterferon beta-1aResearchUSA

AFFiRiS leads consortium for Parkinson’s vaccine funded by EU

AFFiRiS leads consortium for Parkinson’s vaccine funded by EU

29-04-2014

An international consortium of top European research teams has received significant European Union funding…

Achim SchneebergerAFFiRiSAustriaBiologyBiotechnologyEuropeExperts and basic scientistMedical University of Innsbruck's DepartmentMedicineNeurologicalResearchVaccines

Biogen Idec 1st-qtr 2014 revenue leaps 51%, driven by Tecfidera and MS franchise

23-04-2014

US biotech firm Biogen Idec first-quarter 2014 results today, including revenue of $2.1 billion, a 51%…

Biogen IdecBiotechnologyFinancialNeurologicalResearchTecfidera

Alkermes leaps on positive Ph III results for aripiprazole lauroxil for schizophrenia

Alkermes leaps on positive Ph III results for aripiprazole lauroxil for schizophrenia

09-04-2014

US biotech firm Alkermes saw its shares spike on Tuesday, after it announced positive top-line results…

AbilifyAlkermesaripiprazole lauroxilBiotechnologyLundbeckNeurologicalOtsukaRegulationResearch

Convergence Pharma and Evotec collaborate on chronic pain drugs

Convergence Pharma and Evotec collaborate on chronic pain drugs

31-03-2014

Independent UK biotech firm Convergence Pharmaceuticals has entered into a research alliance with Germany’s…

BiotechnologyConvergence PharmaceuticalsEvotecNeurologicalResearch

Xenon and Genentech establish new pain discovery collaboration

26-03-2014

Privately-held US biotech firm Xenon Pharmaceuticals has established a new collaboration with Swiss drug…

BiotechnologyGenentechLicensingNeurologicalResearchRocheXenon Pharmaceuticals

Eisai and Biogen Idec collaborate on Alzheimer’s disease treatments

Eisai and Biogen Idec collaborate on Alzheimer’s disease treatments

05-03-2014

US biotech firm Biogen Idec and Japanese drugmaker Eisai have entered into a collaboration to develop…

BAN2401BIIB037Biogen IdecBiotechnologyE2609EisaiLicensingNeurologicalResearch

1 to 25 of 81 results

Back to top